News | June 04, 2022
Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
The integration and transition of the brands are expected to be completed by June 2022.
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
The patient, who was previously diagnosed with osteoarthritis, was prescribed hip replacement surgery as the best and most effective solution for his condition
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
Subscribe To Our Newsletter & Stay Updated
